Reference:
Yonker, L. M., Swank, Z., Bartsch, Y. C., et al. (2023). Circulating spike protein detected in post–COVID-19 mRNA vaccine myocarditis. Circulation, 147, xxx–xxx. https://doi.org/10.1161/CIRCULATIONAHA.122.061025
Summary:
This study investigates the immunological profiles of adolescents and young adults who developed myocarditis following mRNA COVID-19 vaccination. The research involved blood sampling from 16 patients hospitalised with myocarditis and 45 healthy vaccinated controls. The findings revealed that the immune responses in those who developed myocarditis were largely similar to controls, except for significantly elevated levels of free spike protein in the myocarditis group, suggesting a potential link to the condition. Importantly, no specific autoimmune response or significant differences in T-cell activity were noted. The results indicate that while myocarditis is a rare complication of vaccination, the presence of circulating spike protein could inform future vaccine safety and design without altering the overall risk-benefit ratio favouring vaccination against COVID-19.